PNC Financial Services Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

PNC Financial Services Group’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-512	Closed	-$548	–	4802
2023 Q3	$548	Sell	512 -378	-42%	-$782	﹤0.01%	4449
2023 Q2	$2.31K	Buy	890 +576	+183%	+$2.06K	﹤0.01%	4341
2023 Q1	$1.28K	Buy	314 +48	+18%	+$222	﹤0.01%	4399
2022 Q4	$1.34K	Buy	266 +174	+189%	+$1.09K	﹤0.01%	4351
2022 Q3	$2K	Hold	92	–	–	﹤0.01%	4228
2022 Q2	$2K	Hold	92	–	–	﹤0.01%	4258
2022 Q1	$2K	Hold	92	–	–	﹤0.01%	4247
2021 Q4	$2K	Hold	92	–	–	﹤0.01%	4207
2021 Q3	$2K	Hold	92	–	–	﹤0.01%	4154
2021 Q2	$2K	Hold	92	–	–	﹤0.01%	4066
2021 Q1	$2K	Buy	+92	New	+$2.58K	﹤0.01%	3983

Other funds holding NGM

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group's NGM Position: Q4 2023 in Review

PNC Financial Services Group sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q4 2023, closing a stake of 512 shares — an estimated $548 sold.

PNC Financial Services Group first reported a position in NGM in Q1 2021 and held it in 11 quarters. The position peaked at $2.31K in Q2 2023. 83 funds tracked by Wall St. Rank hold NGM as of Q4 2023.

PNC Financial Services Group reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
PNC Financial Services Group sold 512 NGM Biopharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $548.
PNC Financial Services Group first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
PNC Financial Services Group's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $2.31K in Q2 2023.
83 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on PNC Financial Services Group's 13F filing for Q4 2023, filed 9 Feb 2024.